Epigenetic And Genetic Alterations Affect The WWOX Gene In Head And Neck Squamous Cell Carcinoma
Seda Ekizoğlu, Pelin Bulut, Emin Karaman, Erkan Kilic, Nur Buyru
Published 2015 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Different types of genetic and epigenetic changes are associated with HNSCC. The molecular mechanisms of HNSCC carcinogenesis are still undergoing intensive investigation. WWOX gene expression is altered in many cancers and in a recent work reduced WWOX expression has been associated with miR-134 expression in HNSCC. In this study we investigated the WWOX messenger RNA expression levels in association with the promoter methylation of the WWOX gene and miR-134 expression levels in 80 HNSCC tumor and non-cancerous tissue samples. Our results show that WWOX expression is down-regulated especially in advanced-stage tumor samples or in tumors with SCC. This down-regulation was associated with methylation of the WWOX promoter region but not with miR-134 expression. There was an inverse correlation between the expression level and promoter methylation. We also analyzed whole exons and exon/intron boundries of the WWOX gene by direct sequencing. In our study group we observed 10 different alterations in the coding sequences and 18 different alterations in the non-coding sequences of the WWOX gene in HNSCC tumor samples. These results indicate that the WWOX gene can be functionally inactivated by promoter methylation, epigenetically or by mutations affecting the sequences coding for the enzymatic domain of the gene, functionally. We conclude that inactivation of WWOX gene contributes to the progression of HNSCC.
This paper references
WWOXgene restoration prevents lung cancer growth in vitro and in vivo
M Fabbri (2005)
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
Kenneth J Livak (2001)
Methylation status of WWOX gene promoter CpG islands in epithelial ovarian cancer and its clinical significance.
Hongchao Yan (2013)
The Tumor Suppressor Gene WWOX at FRA16D Is Involved in Pancreatic Carcinogenesis
T. Kuroki (2004)
Inhibition of Breast Cancer Cell Growth In vitro and In vivo: Effect of Restoration of Wwox Expression
D. Iliopoulos (2007)
Genetic alterations of the WWOX gene in breast cancer
Seda Ekizoğlu (2011)
Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo.
R. Aqeilan (2007)
Decreased expression of WWOX in the development of esophageal squamous cell carcinoma.
Wei Guo (2013)
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.
M. Jenner (2007)
Tumors of the hypopharynx, larynx and trachea (Epithelial precursor lesions)
N PBGale (2005)
WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome
María Inés Cavadas Núñez (2005)
WWOX Expression in Different Histologic Types and Subtypes of Non–Small Cell Lung Cancer
V. Donati (2007)
Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status
María Isabel Núñez (2004)
Effects of 5-Aza-2 0 -deoxycytidine on the methylation state and function of the WWOX gene in the HO-8910 ovarian cancer cell line
H Yan (2013)
WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC)
Onur Baykara (2010)
WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.
A. Bednarek (2001)
Loss of WWOX Expression in Gastric Carcinoma
R. Aqeilan (2004)
Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
M. Hashibe (2009)
Effects of 5-Aza-2′-deoxycytidine on the methylation state and function of the WWOX gene in the HO-8910 ovarian cancer cell line
Hongchao Yan (2013)
Cancer statistics, 2012.
Rebecca L Siegel (2012)
Wwox inactivation enhances mammary tumorigenesis
S. Abdeen (2011)
Genetic alterations of theWWOX gene in breast cancer
S Ekizoglu (2012)
WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
A. Bednarek (2000)
Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours.
D Ramos (2008)
WWOX: A candidate tumor suppressor gene involved in multiple tumor types
A. Paige (2001)
Genetic and epigenetic alterations of WWOX in the development of gastric cardia adenocarcinoma.
Wei Guo (2013)
WWOX gene restoration prevents lung cancer growth in vitro and in vivo
M. Fabbri (2005)
The landscape of somatic copy-number alteration across human cancers
R. Beroukhim (2010)
Effects of 5-Aza-20-deoxycytidine on the methylation state and function of the WWOX gene in the HO-8910 ovarian cancer cell line
H Yan (2013)
Recent advances in head and neck cancer.
R. Haddad (2008)
N Dubrawsky (1989)
WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.
C Marcelo Aldaz (2014)
Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma.
T. Kuroki (2002)
Targeted deletion of Wwox reveals a tumor suppressor function
R. Aqeilan (2007)
Tumors of the hypopharynx, larynx and trachea (Epithelial precursor lesions) World Health Organization Classification of Tumours Pathology&Genetics Head and Neck Tumours
N Gale (2005)
miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
Chung-Ji Liu (2014)
Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells.
K. Ried (2000)
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma.
Lisa Cancemi (2011)
Expression profiling in primates reveals a rapid evolution of human transcription factors
Y. Gilad (2006)
2005)WWOXgene restoration prevents lung cancer growth in vitro and in vivo
M Fabbri (2005)
Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer
D. Iliopoulos (2005)
Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas.
F. Pimenta (2006)
This paper is referenced by
Analysis of WWOX gene expression and protein levels in pterygium
Nihan Bozkurt (2020)
Integrated analysis of the miRNA-mRNA network associated with LMP1 gene in nasopharyngeal carcinoma
Yang Yang (2019)
How DNA methylation affects the Warburg effect
Xingxin Zhu (2020)
Functions and Epigenetic Regulation of Wwox in Bone Metastasis from Breast Carcinoma: Comparison with Primary Tumors
Paola Maroni (2017)
Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases
Xiao-ning Gan (2017)
Genomic Alteration in Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Inferred from Karyotyping, Molecular Cytogenetics, and Array Comparative Genomic Hybridization
Worapong Singchat (2016)
Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance.
Hiroshi Handa (2017)
Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk
Hsin-Lin Cheng (2016)
Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk
Hsiang-lin Lee (2017)
Silencing of Wwox Increases Nuclear Import of Dvl proteins in Head and Neck Cancer
Asuman Çelebi (2020)
Role of Genetic and Epigenetic Factors in Oral Squamous Cell Carcinoma - A Structured Review
D. B. Manjunatha (2015)
WWOX inhibits the invasion of lung cancer cells by downregulating RUNX2
Q-W Zheng (2016)
miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
Shih-Yuan Peng (2018)